you are viewing a single comment's thread
view the rest of the comments
[–] 62 points 3 weeks ago (2 children)

Remember when Tylenol was linked to autism, crashing the stock price of its maker just long enough for that business to be acquired at a steep discount by its new owner? And how we never heard about a link between Tylenol and autism again?

I wonder which vaccine maker is about to get a hostile takeover?

  • source
  • hideshow 4 child comments
  • [–] 11 points 3 weeks ago (1 child)

    I don’t who is the new owner? Bayer? ‘Cause that’d fit.

  • source
  • parent
  • hideshow 2 child comments
  • [–] 17 points 3 weeks ago (3 children)

    Kimberly-Clark apparently.

    In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson's Baby, Sudafed, Visine, and Zyrtec brands to the company's portfolio.

    But also...

    Kimberly-Clark shares are mainly held by institutional investors (The Vanguard Group, BlackRock, State Street Corporation, and others).

    So make of that what you will.

  • source
  • parent
  • hideshow 6 child comments
  • [–] 3 points 3 weeks ago

    In November 2025, Kimberly-Clark announced it would buy Tylenol producer Kenvue for $48.7 billion. The deal would add the Aveeno, Band-Aid, Benadryl, Benylin, Calpol, Carefree, Clean & Clear, Combantrin, Imodium, Listerine, Motrin, Mylanta, Neutrogena, Nicorette, Johnson's Baby, Sudafed, Visine, and Zyrtec brands to the company's portfolio.[34][35]

  • source
  • parent